Agilent and Monash Malaysia launch cutting-edge BioDiscovery hub to boost regional biotech
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
Fresh Phase 1b/2a data highlight the strength of the iberdomide + daratumumab + dexamethasone combination in transplant-deferred or ineligible NDMM
Patients can now get the starting 2.5 mg dose for $299 per month
Companies in the pharmaceutical industry must shift from L1 (lowest-bid) costing to Life Cycle Cost Analysis (LCCA) to achieve long-term cost optimization, improve decision-making, and enhance sustainability
The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
Jaypirca is making waves in the fight against B-cell malignancies
Desai is currently serving the company as Group Finance Controller
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
Subscribe To Our Newsletter & Stay Updated